← Back to Search

Behavioral Intervention

Mobile Health Intervention for Weight Gain Prevention

N/A
Recruiting
Led By Deborah F. Tate, PhD
Research Sponsored by University of North Carolina, Chapel Hill
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Age 18-39
Be between 18 and 65 years old
Must not have
Past diagnosis of or receiving treatment for a clinically diagnosed eating disorder (anorexia nervosa or bulimia nervosa)
Previous surgical procedure for weight loss in past 5 years or planned weight loss surgery in the next year
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 2 years
Awards & highlights
No Placebo-Only Group

Summary

This trial aims to adapt a weight gain prevention program for young adults in the military using mobile tech to prevent weight gain over 2 years.

Who is the study for?
This trial is for active-duty Air Force members aged 18-39 stationed at select bases, with a BMI of 21-30. Participants must own a smartphone, expect to be at their base for over a year, and be willing to wear a Fitbit daily. Pregnant individuals or those planning pregnancy soon, people who've had weight loss surgery recently or plan to have it, and anyone with past eating disorders or in another weight loss program cannot join.
What is being tested?
The study tests an mHealth intervention called 'Fit for Duty-mobile' designed to prevent weight gain among young adult military personnel using mobile technology over two years. It adapts an evidence-based approach specifically for this population.
What are the potential side effects?
Since the intervention involves lifestyle changes through mobile health guidance and activity tracking rather than medication, typical medical side effects are not expected. However, participants may experience changes in physical activity patterns.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I am between 18 and 39 years old.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with or am being treated for an eating disorder.
Select...
I have had or plan to have weight loss surgery within 6 years.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 years for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Secondary study objectives
Change in Competence for Diet and Physical Activity
Change in Depression as measured by the CESD-Short Form
Change in Dietary Intake as measured by the ASA-24 hour Recall
+14 more
Other study objectives
Adoption (Re-AIM)
Effectiveness (Re-AIM)
Implementation (Re-AIM)
+2 more

Awards & Highlights

No Placebo-Only Group
All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Fit for Duty MobileExperimental Treatment1 Intervention
This arm receives a digital fitness tracker; digital scale; smartphone app which delivers a behavioral weight gain prevention intervention; and periodic coaching calls.
Group II: m-Health ControlActive Control1 Intervention
This arm receives a digital fitness tracker, digital scale, and basic information about behavioral approaches for weight gain prevention.

Find a Location

Who is running the clinical trial?

National Heart, Lung, and Blood Institute (NHLBI)NIH
3,943 Previous Clinical Trials
47,797,445 Total Patients Enrolled
255 Trials studying Obesity
211,222 Patients Enrolled for Obesity
University of VirginiaOTHER
785 Previous Clinical Trials
1,315,992 Total Patients Enrolled
18 Trials studying Obesity
2,009 Patients Enrolled for Obesity
University of North Carolina, Chapel HillLead Sponsor
1,569 Previous Clinical Trials
4,319,130 Total Patients Enrolled
66 Trials studying Obesity
58,246 Patients Enrolled for Obesity
Deborah F. Tate, PhDPrincipal InvestigatorProfessor
7 Previous Clinical Trials
1,341 Total Patients Enrolled
4 Trials studying Obesity
1,181 Patients Enrolled for Obesity
~303 spots leftby Feb 2027